Citation Tools

Download PDFPDF
0099: Analysis of Gemcitabine As Second or Third Line Therapy for Recurrent Ovarian Cancer or Primary Peritoneal Cancer

Download to a citation manager

Cite this article as:
Nishimura M, Furumoto H, Abe A, et al
0099: Analysis of Gemcitabine As Second or Third Line Therapy for Recurrent Ovarian Cancer or Primary Peritoneal Cancer